MBRX (STOCKS)
Moleculin Biotech, Inc.
$2.700000
+0.080000 (+3.05%)
Prev close: $2.620000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Walter V. Klemp
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.57M
- Employees
- 17
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $25.10M |
| Research and Development | $15.89M |
| Other Operating Expenses | $9.21M |
| Operating Income/Loss | -$25.10M |
| Income/Loss From Continuing Operations After Tax | -$33.56M |
| Income/Loss From Continuing Operations Before Tax | -$33.56M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$33.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$33.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $104.00K |
| Preferred Stock Dividends And Other Adjustments | $104.00K |
| Basic Earnings Per Share | -$28.42 |
| Basic Average Shares | 1,184,569 |
| Assets | $22.13M |
| Current Assets | $9.69M |
| Noncurrent Assets | $12.44M |
| Fixed Assets | $78.00K |
| Other Non-current Assets | $12.36M |
| Liabilities | $7.12M |
| Current Liabilities | $6.85M |
| Accounts Payable | $3.51M |
| Wages | $1.82M |
| Other Current Liabilities | $1.53M |
| Noncurrent Liabilities | $266.00K |
| Equity | $15.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $15.01M |
| Liabilities And Equity | $22.13M |
| Net Cash Flow From Operating Activities | -$22.74M |
| Net Cash Flow From Operating Activities, Continuing | -$22.74M |
| Net Cash Flow From Investing Activities | -$4.60M |
| Net Cash Flow From Investing Activities, Continuing | -$4.55M |
| Net Cash Flow From Financing Activities | $27.28M |
| Net Cash Flow From Financing Activities, Continuing | $27.28M |
| Exchange Gains/Losses | $51.00K |
| Net Cash Flow | -$51.00K |
| Net Cash Flow, Continuing | -$102.00K |
| Comprehensive Income/Loss | -$33.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.51M |
| Other Comprehensive Income/Loss | -$33.51M |